An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers

por Elishmereni, Moran, Kheifetz, Yuri, Søndergaard, Henrik, Overgaard, Rune Viig, Agur, Zvia
Publicado 2011

Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease

por Holm, Thomas Lindebo, Tornehave, Ditte, Søndergaard, Henrik, Kvist, Peter Helding, Sondergaard, Bodil-Cecilie, Hansen, Lene, Hermit, Mette Brunsgaard, Holgersen, Kristine, Vergo, Sandra, Frederiksen, Klaus Stensgaard, Haase, Claus, Lundsgaard, Dorthe
Publicado 2018

Antibody-Mediated Targeting of the Orai1 Calcium Channel Inhibits T Cell Function

por Cox, Jennifer H., Hussell, Scott, Søndergaard, Henrik, Roepstorff, Kirstine, Bui, John-Vu, Deer, Jen Running, Zhang, Jun, Li, Zhan-Guo, Lamberth, Kasper, Kvist, Peter Helding, Padkjær, Søren, Haase, Claus, Zahn, Stefan, Odegard, Valerie H.
Publicado 2013